{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:37:23Z","timestamp":1787161043303,"version":"build-2736575974"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T00:00:00Z","timestamp":1456444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0149848","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T13:52:25Z","timestamp":1456494745000},"page":"e0149848","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR\/NLR High-Throughput Screen"],"prefix":"10.1371","volume":"11","author":[{"given":"Alex C. D.","family":"Salyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma K.","family":"Khetani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subbalakshmi S.","family":"Malladi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil A.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,2,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2471\/BLT.07.040089","article-title":"Vaccination greatly reduces disease, disability, death and inequity worldwide","volume":"86","author":"FE Andre","year":"2008","journal-title":"Bull World Health Organ"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/icb.2009.15","article-title":"Vaccines, global health and social equity","volume":"87","author":"MM Levine","year":"2009","journal-title":"Immunol Cell Biol"},{"key":"ref3","first-page":"99","article-title":"The history of smallpox eradication","author":"DA Henderson","year":"1980","journal-title":"Henry E Sigerist Suppl Bull Hist Med"},{"issue":"Suppl 4","key":"ref4","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","article-title":"The eradication of smallpox\u2014an overview of the past, present, and future","volume":"29","author":"DA Henderson","year":"2011","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/tropej\/37.6.272","article-title":"The children&apos;s vaccine initiative\u2026and other promises to keep","volume":"37","author":"JP Grant","year":"1991","journal-title":"J Trop Pediatr"},{"key":"ref6","first-page":"152","article-title":"The children&apos;s vaccine initiative","volume":"147","author":"A Robbins","year":"1993","journal-title":"Am J Dis Child"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/8332","article-title":"The sun sets on the CVI. Children&apos;s Vaccine Initiative","volume":"5","author":"K Birmingham","year":"1999","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fpubh.2015.00269","article-title":"Vaccines Through Centuries: Major Cornerstones of Global Health","volume":"3","author":"I Hajj Hussein","year":"2015","journal-title":"Front Public Health"},{"key":"ref9","first-page":"1709","article-title":"Vaccines: the fourth century","volume":"16","author":"SA Plotkin","year":"2009","journal-title":"ClinVaccine Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpharm.2015.06.030","article-title":"The potential of adjuvants to improve immune responses against TdaP vaccines: A preclinical evaluation of MF59 and monophosphoryl lipid A","volume":"492","author":"V Agnolon","year":"2015","journal-title":"Int J Pharm"},{"key":"ref11","first-page":"151","article-title":"Inactivated and adjuvanted influenza vaccines","volume":"386","author":"G Del Giudice","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.4161\/hv.24715","article-title":"The potential of 1018 ISS adjuvant in hepatitis B vaccines: HEPLISAV review","volume":"9","author":"NF Eng","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/21645515.2014.987014","article-title":"Immunogenicity and safety of cell-derived MF59(R)-adjuvanted A\/H1N1 influenza vaccine for children","volume":"11","author":"M Knuf","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.vaccine.2014.10.085","article-title":"Safety and immunogenicity of an MF59-adjuvanted A\/H1N1 pandemic influenza vaccine in children from three to seventeen years of age","volume":"33","author":"M Knuf","year":"2015","journal-title":"Vaccine"},{"key":"ref15","article-title":"Randomized Controlled Trial of Adjuvanted Versus Nonadjuvanted Influenza Vaccine in Kidney Transplant Recipients","author":"D Kumar","year":"2015","journal-title":"Transplantation"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0169-409X(98)00008-8","article-title":"Aluminum compounds as vaccine adjuvants","volume":"32","author":"RK Gupta","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"key":"ref17","first-page":"38","article-title":"The antigenic value of toxoid precipitated by potassium-alum","volume":"29","author":"AT Glenny","year":"1926","journal-title":"J Path Bact"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.4.5.6438","article-title":"Vaccine adjuvants: the dream becomes real","volume":"4","author":"A Tagliabue","year":"2008","journal-title":"Hum Vaccin"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/INF.0b013e318206c26e","article-title":"Immunogenicity and safety of human papillomavirus-16\/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study","volume":"30","author":"S Esposito","year":"2011","journal-title":"Pediatr Infect DisJ"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.vaccine.2011.04.046","article-title":"The safety evaluation of adjuvants during vaccine development: The AS04 experience","volume":"29","author":"N Garcon","year":"2011","journal-title":"Vaccine"},{"key":"ref21","unstructured":"NIAID Strategic Plan for Research on Vaccine Adjuvants. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.niaid.nih.gov\/about\/organization\/dait\/adjuvantplan\/pages\/default.aspx?wt.ac=bcAdjuvantplan\" xlink:type=\"simple\">https:\/\/www.niaid.nih.gov\/about\/organization\/dait\/adjuvantplan\/pages\/default.aspx?wt.ac=bcAdjuvantplan<\/ext-link>."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ceb.2007.02.006","article-title":"Signaling pathways activated by microorganisms","volume":"19","author":"O Takeuchi","year":"2007","journal-title":"Curr Opin Cell Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10156-008-0596-1","article-title":"Pathogen recognition by innate receptors","volume":"14","author":"Y Kumagai","year":"2008","journal-title":"J Infect Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jaci.2010.01.058","article-title":"Identification and functions of pattern-recognition receptors","volume":"125","author":"Y Kumagai","year":"2010","journal-title":"JAllergy Clin Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM200008033430506","article-title":"Innate immunity","volume":"343","author":"R Medzhitov","year":"2000","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"Innate immunity: impact on the adaptive immune response","volume":"9","author":"R Medzhitov","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.161.2.539","article-title":"Presidential Address to The American Association of Immunologists. The road less traveled by: the role of innate immunity in the adaptive immune response","volume":"161","author":"CAJ Janeway","year":"1998","journal-title":"J Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tips.2009.03.005","article-title":"Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants","volume":"30","author":"V Aimanianda","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1084\/jem.20071087","article-title":"Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells","volume":"205","author":"M Kool","year":"2008","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.01.008","article-title":"Innate immunity","volume":"25","author":"J Hoffmann","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"T Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"YM Loo","year":"2011","journal-title":"Immunity"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cytogfr.2011.09.003","article-title":"NOD-like receptors and the innate immune system: coping with danger, damage and death","volume":"22","author":"K Kersse","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1600-065X.2011.01039.x","article-title":"Intracellular sensors of extracellular bacteria","volume":"243","author":"TB Clarke","year":"2011","journal-title":"Immunol Rev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.imbio.2013.07.007","article-title":"The interferon response to intracellular DNA: why so many receptors?","volume":"218","author":"L Unterholzner","year":"2013","journal-title":"Immunobiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.cell.2013.08.014","article-title":"Cyclic dinucleotides and the innate immune response","volume":"154","author":"O Danilchanka","year":"2013","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-065X.2011.01051.x","article-title":"Cytoplasmic DNA innate immune pathways","volume":"243","author":"GN Barber","year":"2011","journal-title":"Immunol Rev"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/jm3000533","article-title":"Structure-activity relationships in human Toll-like receptor 2-specific monoacyl lipopeptides","volume":"55","author":"DB Salunke","year":"2012","journal-title":"J Med Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1021\/jm400620g","article-title":"Design and development of stable, water-soluble, human Toll-like receptor 2 specific monoacyl lipopeptides as candidate vaccine adjuvants","volume":"56","author":"DB Salunke","year":"2013","journal-title":"J Med Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1021\/jm901839g","article-title":"Structure-activity relationships in toll-like receptor-2 agonistic diacylthioglycerol lipopeptides","volume":"53","author":"W Wu","year":"2010","journal-title":"J Med Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.bmcl.2009.02.100","article-title":"Regioisomerism-dependent TLR7 agonism and antagonism in an imidazoquinoline","volume":"19","author":"NM Shukla","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1021\/jm100358c","article-title":"Structure-activity relationships in human toll-like receptor 7-active imidazoquinoline analogues","volume":"53","author":"NM Shukla","year":"2010","journal-title":"J Med Chem"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1016\/j.bmcl.2010.09.093","article-title":"Syntheses of fluorescent imidazoquinoline conjugates as probes of Toll-like receptor 7","volume":"20","author":"NM Shukla","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.bmcl.2011.04.050","article-title":"Toward self-adjuvanting subunit vaccines: model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines","volume":"21","author":"NM Shukla","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1016\/j.bmc.2011.04.052","article-title":"Preliminary evaluation of a 3<italic>H<\/italic> imidazoquinoline library as dual TLR7\/TLR8 antagonists","volume":"19","author":"NM Shukla","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/jm2010207","article-title":"Toll-Like Receptor (TLR)-7 and -8 Modulatory Activities of Dimeric Imidazoquinolines","volume":"55","author":"NM Shukla","year":"2012","journal-title":"J Med Chem"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e43612","DOI":"10.1371\/journal.pone.0043612","article-title":"Potent adjuvanticity of a pure TLR7-agonistic imidazoquinoline dendrimer","volume":"7","author":"NM Shukla","year":"2012","journal-title":"PLoS ONE"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1039\/c3ob40816g","article-title":"Structure-activity relationships in Toll-like receptor 7 agonistic 1H-imidazo[4,5-<italic>c<\/italic>]pyridines","volume":"11","author":"E Yoo","year":"2013","journal-title":"Org Biomol Chem"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7955","DOI":"10.1021\/jm500744f","article-title":"Determinants of activity at human Toll-like receptors 7 and 8: quantitative structure-activity relationship (QSAR) of diverse heterocyclic scaffolds","volume":"57","author":"E Yoo","year":"2014","journal-title":"J Med Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1021\/jm301066h","article-title":"Structure-activity relationships in human Toll-like receptor 8-active 2,3-diamino-furo[2,3-<italic>c<\/italic>]pyridines","volume":"55","author":"DB Salunke","year":"2012","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1039\/c2ob26705e","article-title":"Toll-like receptor-8 agonistic activities in C2, C4, and C8 modified thiazolo[4,5-<italic>c<\/italic>]quinolines","volume":"11","author":"HP Kokatla","year":"2013","journal-title":"Org Biomol Chem"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1021\/jm400694d","article-title":"Exquisite Selectivity for Human Toll-Like Receptor 8 in Substituted Furo[2,3-<italic>c<\/italic>]quinolines","volume":"56","author":"HP Kokatla","year":"2013","journal-title":"J Med Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/cmdc.201300573","article-title":"Structure-based design of novel human Toll-like receptor 8 agonists","volume":"9","author":"HP Kokatla","year":"2014","journal-title":"ChemMedChem"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.1021\/jm500701q","article-title":"Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1<italic>H<\/italic>-benzimidazol-2-amines","volume":"57","author":"M Beesu","year":"2014","journal-title":"J Med Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/jm101535e","article-title":"Structure-activity relationships in nucleotide oligomerization domain 1 (Nod1) agonistic gamma-glutamyldiaminopimelic acid derivatives","volume":"54","author":"G Agnihotri","year":"2011","journal-title":"J Med Chem"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bmcl.2011.11.014","article-title":"Potent adjuvantic activity of a CCR1-agonistic <italic>bis<\/italic>-quinoline","volume":"22","author":"R Ukani","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"JH Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/jps.21179","article-title":"Amphotericin B formulations and drug targeting","volume":"97","author":"JJ Torrado","year":"2008","journal-title":"J Pharm Sci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"5229","DOI":"10.1073\/pnas.1201964109","article-title":"Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197","volume":"109","author":"E Malito","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0192-0561(98)00068-X","article-title":"Imiquimod applied topically: a novel immune response modifier and new class of drug","volume":"21","author":"RL Miller","year":"1999","journal-title":"Int J Immunopharmacol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1021\/jm049211v","article-title":"Synthesis and structure-activity-relationships of 1H-imidazo[4,5-<italic>c<\/italic>]quinolines that induce interferon production","volume":"48","author":"JF Gerster","year":"2005","journal-title":"J Med Chem"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1021\/jm4004957","article-title":"Structure-activity relationship analysis of imidazoquinolines with Toll-like receptors 7 and 8 selectivity and enhanced cytokine induction","volume":"57","author":"CE Schiaffo","year":"2014","journal-title":"J Med Chem"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1021\/jm400815m","article-title":"Identification and optimization of pteridinone Toll-like receptor 7 (TLR7) agonists for the oral treatment of viral hepatitis","volume":"56","author":"PA Roethle","year":"2013","journal-title":"J Med Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.bmcl.2012.11.114","article-title":"Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility","volume":"23","author":"T Nakamura","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"6871","DOI":"10.1021\/jm901145s","article-title":"Toll-like receptor 7 selective synthetic oligoribonucleotide agonists: synthesis and structure-activity relationship studies","volume":"52","author":"T Lan","year":"2009","journal-title":"J Med Chem"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1021\/jm100070n","article-title":"Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept","volume":"53","author":"A Kurimoto","year":"2010","journal-title":"J Med Chem"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.bmcl.2015.01.037","article-title":"Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives","volume":"25","author":"HG Bazin","year":"2015","journal-title":"Bioorg Med Chem Lett"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1021\/acs.jmedchem.5b01087","article-title":"Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity","volume":"58","author":"M Beesu","year":"2015","journal-title":"J Med Chem"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.bmcl.2014.09.039","article-title":"Discovery of substituted 4-aminoquinazolines as selective Toll-like receptor 4 ligands","volume":"24","author":"A Nour","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/jpet.114.214312","article-title":"Novel synthetic toll-like receptor 4\/MD2 ligands attenuate sterile inflammation","volume":"350","author":"T Hayashi","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1021\/jm301694x","article-title":"Identification of substituted pyrimido[5,4-<italic>b<\/italic>]indoles as selective Toll-like receptor 4 ligands","volume":"56","author":"M Chan","year":"2013","journal-title":"J Med Chem"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1128\/JVI.03337-14","article-title":"Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses","volume":"89","author":"PH Goff","year":"2015","journal-title":"J Virol"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"e1400139","DOI":"10.1126\/sciadv.1400139","article-title":"Specific activation of the TLR1-TLR2 heterodimer by small-molecule agonists","volume":"1","author":"K Cheng","year":"2015","journal-title":"Sci Adv"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"23755","DOI":"10.1074\/jbc.M110.116046","article-title":"Identification of novel synthetic toll-like receptor 2 agonists by high throughput screening","volume":"285","author":"Y Guan","year":"2010","journal-title":"J Biol Chem"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"16739","DOI":"10.1074\/jbc.M414139200","article-title":"Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes","volume":"280","author":"K Li","year":"2005","journal-title":"J Biol Chem"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"8194","DOI":"10.1128\/JVI.00640-14","article-title":"MDA5 and LGP2: accomplices and antagonists of antiviral signal transduction","volume":"88","author":"KR Rodriguez","year":"2014","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.cell.2007.09.008","article-title":"Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide","volume":"130","author":"MS Jin","year":"2007","journal-title":"Cell"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1297-9716-44-50","article-title":"The molecular basis for recognition of bacterial ligands at equine TLR2, TLR1 and TLR6","volume":"44","author":"KL Irvine","year":"2013","journal-title":"Vet Res"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1073\/pnas.1417945112","article-title":"Flagellin-induced NLRC4 phosphorylation primes the inflammasome for activation by NAIP5","volume":"112","author":"M Matusiak","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ni.1646","article-title":"Critical function for Naip5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin","volume":"9","author":"KL Lightfield","year":"2008","journal-title":"Nat Immunol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"37561","DOI":"10.1074\/jbc.M306137200","article-title":"The antifungal drug amphotericin B promotes inflammatory cytokine release by a Toll-like receptor- and CD14-dependent mechanism","volume":"278","author":"K Sau","year":"2003","journal-title":"J Biol Chem"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1128\/AAC.49.4.1617-1621.2005","article-title":"Secretion of proinflammatory cytokines and chemokines during amphotericin B exposure is mediated by coactivation of toll-like receptors 1 and 2","volume":"49","author":"RR Razonable","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/mp9001602","article-title":"Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity","volume":"6","author":"SA Adediran","year":"2009","journal-title":"Mol Pharm"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/clinids\/12.2.308","article-title":"Amphotericin B: 30 years of clinical experience","volume":"12","author":"HA Gallis","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"Suppl 1","key":"ref85","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1378\/chest.54.Supplement_1.296","article-title":"The discovery and development of amphotericin B","volume":"54","author":"JD Dutcher","year":"1968","journal-title":"Dis Chest"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/mp100363f","article-title":"Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin","volume":"8","author":"TP Day","year":"2011","journal-title":"Mol Pharm"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1189\/jlb.0807586","article-title":"Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling","volume":"83","author":"K Farhat","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1111\/j.1742-4658.2005.05029.x","article-title":"Lipopeptide structure determines TLR2 dependent cell activation level","volume":"272","author":"U Buwitt-Beckmann","year":"2005","journal-title":"FEBS J"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"V Mata-Haro","year":"2007","journal-title":"Science"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s00018-008-8228-6","article-title":"Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant","volume":"65","author":"CR Casella","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"ra13","DOI":"10.1126\/scisignal.2001963","article-title":"Selective TRIF-dependent signaling by a synthetic toll-like receptor 4 agonist","volume":"5","author":"WS Bowen","year":"2012","journal-title":"Sci Signal"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jac\/33.2.203","article-title":"Administering amphotericin B\u2014a practical approach","volume":"33","author":"SH Khoo","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM198806093182301","article-title":"Detection of circulating tumor necrosis factor after endotoxin administration","volume":"318","author":"HR Michie","year":"1998","journal-title":"N Engl J Med"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0171-2985(11)80353-0","article-title":"Response of man to endotoxin","volume":"187","author":"GD Martich","year":"1993","journal-title":"Immunobiol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1056\/NEJM198908033210503","article-title":"The cardiovascular response of normal humans to the administration of endotoxin","volume":"321","author":"AF Suffredini","year":"1989","journal-title":"N Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0149848","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T21:33:20Z","timestamp":1692221600000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0149848"}},"subtitle":[],"editor":[{"given":"Suryaprakash","family":"Sambhara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,26]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0149848","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,26]]}}}